SEC Form 4 · accession 0001209191-15-051946
Tvardi Therapeutics, Inc. · TVRD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harrison M Bains Jr.
Director
Period of report
Jun 8, 2015
Accepted (ET)
Jun 10, 2015 · 5:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001346830
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.94 | Jun 8, 2015 | A | 13,500 | A | — | Jun 8, 2025 | Common Stock | 13,500 | 13,500 | D |
Explanation of responses
- F1This option was granted to the reporting person pursuant to the issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on June 8, 2016, subject to the reporting person's continued service as a director through such date.